Giuseppe Gaetano Loscocco

CALR ‐mutated myeloproliferative neoplasms: Refining molecular risk beyond the driver

Calreticulin ( CALR )‐mutated myeloproliferative neoplasms (MPNs) are generally associated with favourable outcomes, yet considerable heterogeneity persists across the disease course. Mawalkar et al. provide long‐term data across essential thrombocythaemia (ET), post‐ET myelofibr...